Company

Modifi Bio

Modifi Bio develops oral cancer treatments designed to modify cancer cell DNA.

About

Founded by Seth Herzon, Bindra, Lin, and Kevin Rakin, Modifi Biosciences is based in New Haven, US. It develops molecules designed to selectively kill cancer cells through direct DNA modification. In July 2022, it raised USD 6.4 million in seed funding from HighCape Partners, Ironwood Capital, Connecticut Innovations, National Brain Tumor Society, and Yale University. Merck & Co., Inc. acquired the company for USD 30 million in October 2024.

2Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in